Kinetics of PKCε activating and inhibiting llama single chain antibodies and their effect on PKCε translocation in HeLa cells.

Dysregulation of PKCε is involved in several serious diseases such as cancer, type II diabetes and Alzheimer's disease. Therefore, specific activators and inhibitors of PKCε hold promise as future therapeutics, in addition to being useful in research into PKCε regulated pathways. We have previo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Milla Summanen, Niko Granqvist, Raimo K Tuominen, Marjo Yliperttula, C Theo Verrips, Johannes Boonstra, Christophe Blanchetot, Elina Ekokoski
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9b60389161564e70bffc909754728330
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9b60389161564e70bffc909754728330
record_format dspace
spelling oai:doaj.org-article:9b60389161564e70bffc9097547283302021-11-18T07:21:24ZKinetics of PKCε activating and inhibiting llama single chain antibodies and their effect on PKCε translocation in HeLa cells.1932-620310.1371/journal.pone.0035630https://doaj.org/article/9b60389161564e70bffc9097547283302012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22536418/?tool=EBIhttps://doaj.org/toc/1932-6203Dysregulation of PKCε is involved in several serious diseases such as cancer, type II diabetes and Alzheimer's disease. Therefore, specific activators and inhibitors of PKCε hold promise as future therapeutics, in addition to being useful in research into PKCε regulated pathways. We have previously described llama single chain antibodies (VHHs) that specifically activate (A10, C1 and D1) or inhibit (E6 and G8) human recombinant PKCε. Here we report a thorough kinetic analysis of these VHHs. The inhibiting VHHs act as non-competitive inhibitors of PKCε activity, whereas the activating VHHs have several different modes of action, either increasing V(max) and/or decreasing K(m) values. We also show that the binding of the VHHs to PKCε is conformation-dependent, rendering the determination of affinities difficult. Apparent affinities are in the micromolar range based on surface plasmon resonance studies. Furthermore, the VHHs have no effect on the activity of rat PKCε nor can they bind the rat form of the protein in immunoprecipitation studies despite the 98% identity between the human and rat PKCε proteins. Finally, we show for the first time that the VHHs can influence PKCε function also in cells, since an activating VHH increases the rate of PKCε translocation in response to PMA in HeLa cells, whereas an inhibiting VHH slows down the translocation. These results give insight into the mechanisms of PKCε activity modulation and highlight the importance of protein conformation on VHH binding.Milla SummanenNiko GranqvistRaimo K TuominenMarjo YliperttulaC Theo VerripsJohannes BoonstraChristophe BlanchetotElina EkokoskiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 4, p e35630 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Milla Summanen
Niko Granqvist
Raimo K Tuominen
Marjo Yliperttula
C Theo Verrips
Johannes Boonstra
Christophe Blanchetot
Elina Ekokoski
Kinetics of PKCε activating and inhibiting llama single chain antibodies and their effect on PKCε translocation in HeLa cells.
description Dysregulation of PKCε is involved in several serious diseases such as cancer, type II diabetes and Alzheimer's disease. Therefore, specific activators and inhibitors of PKCε hold promise as future therapeutics, in addition to being useful in research into PKCε regulated pathways. We have previously described llama single chain antibodies (VHHs) that specifically activate (A10, C1 and D1) or inhibit (E6 and G8) human recombinant PKCε. Here we report a thorough kinetic analysis of these VHHs. The inhibiting VHHs act as non-competitive inhibitors of PKCε activity, whereas the activating VHHs have several different modes of action, either increasing V(max) and/or decreasing K(m) values. We also show that the binding of the VHHs to PKCε is conformation-dependent, rendering the determination of affinities difficult. Apparent affinities are in the micromolar range based on surface plasmon resonance studies. Furthermore, the VHHs have no effect on the activity of rat PKCε nor can they bind the rat form of the protein in immunoprecipitation studies despite the 98% identity between the human and rat PKCε proteins. Finally, we show for the first time that the VHHs can influence PKCε function also in cells, since an activating VHH increases the rate of PKCε translocation in response to PMA in HeLa cells, whereas an inhibiting VHH slows down the translocation. These results give insight into the mechanisms of PKCε activity modulation and highlight the importance of protein conformation on VHH binding.
format article
author Milla Summanen
Niko Granqvist
Raimo K Tuominen
Marjo Yliperttula
C Theo Verrips
Johannes Boonstra
Christophe Blanchetot
Elina Ekokoski
author_facet Milla Summanen
Niko Granqvist
Raimo K Tuominen
Marjo Yliperttula
C Theo Verrips
Johannes Boonstra
Christophe Blanchetot
Elina Ekokoski
author_sort Milla Summanen
title Kinetics of PKCε activating and inhibiting llama single chain antibodies and their effect on PKCε translocation in HeLa cells.
title_short Kinetics of PKCε activating and inhibiting llama single chain antibodies and their effect on PKCε translocation in HeLa cells.
title_full Kinetics of PKCε activating and inhibiting llama single chain antibodies and their effect on PKCε translocation in HeLa cells.
title_fullStr Kinetics of PKCε activating and inhibiting llama single chain antibodies and their effect on PKCε translocation in HeLa cells.
title_full_unstemmed Kinetics of PKCε activating and inhibiting llama single chain antibodies and their effect on PKCε translocation in HeLa cells.
title_sort kinetics of pkcε activating and inhibiting llama single chain antibodies and their effect on pkcε translocation in hela cells.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/9b60389161564e70bffc909754728330
work_keys_str_mv AT millasummanen kineticsofpkceactivatingandinhibitingllamasinglechainantibodiesandtheireffectonpkcetranslocationinhelacells
AT nikogranqvist kineticsofpkceactivatingandinhibitingllamasinglechainantibodiesandtheireffectonpkcetranslocationinhelacells
AT raimoktuominen kineticsofpkceactivatingandinhibitingllamasinglechainantibodiesandtheireffectonpkcetranslocationinhelacells
AT marjoyliperttula kineticsofpkceactivatingandinhibitingllamasinglechainantibodiesandtheireffectonpkcetranslocationinhelacells
AT ctheoverrips kineticsofpkceactivatingandinhibitingllamasinglechainantibodiesandtheireffectonpkcetranslocationinhelacells
AT johannesboonstra kineticsofpkceactivatingandinhibitingllamasinglechainantibodiesandtheireffectonpkcetranslocationinhelacells
AT christopheblanchetot kineticsofpkceactivatingandinhibitingllamasinglechainantibodiesandtheireffectonpkcetranslocationinhelacells
AT elinaekokoski kineticsofpkceactivatingandinhibitingllamasinglechainantibodiesandtheireffectonpkcetranslocationinhelacells
_version_ 1718423614393417728